ロード中...
Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition
Selenium supplement has been shown in clinical trials to reduce the risk of different cancers including lung carcinoma. Previous studies reported that the antiproliferative and pro-apoptotic activities of methylseleninic acid (MSA) in cancer cells could be mediated by inhibition of the PI3K pathway....
保存先:
| 出版年: | Pharmacol Res |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4850087/ https://ncbi.nlm.nih.gov/pubmed/26375988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2015.09.009 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|